Although relationships between TGF-β and AT1R signaling pathways in MFS remain elusive, the blockade of Angiotensin II (AngII) type 1 receptor (AT1R) signals has been proven effective in preventing ERK1/2 activation and aneurysmal progression (Figure 3). This evidence concerns the gene MAPK3 and Marfan syndrome.